Cases & Deals

  • Home
  • Practices
  • Laekna develops global patent portfolios related to various antibody and small molecule drug therapies

Share

Laekna develops global patent portfolios related to various antibody and small molecule drug therapies

December 2023

Client(s) Laekna Therapeutics Shanghai Co., Ltd.

Jones Day is representing Laekna, Inc. in connection with the development of global patent portfolios related to novel therapeutic antibody and small molecule drug candidates for use in the treatment of various disorders, including cancer, liver fibrosis, and metabolic diseases.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.